Switcher

  • <img class="language-icon" typeof="foaf:Image" src="http://www.averbis.de/sites/all/modules/languageicons/flags/en.png" width="16" height="12" alt="English" title="English" />
  • <img class="language-icon" typeof="foaf:Image" src="http://www.averbis.de/sites/all/modules/languageicons/flags/de.png" width="16" height="12" alt="Deutsch" title="Deutsch" />

Pharmaceutical

From research to clinical studies: Pharmaceutical companies generate extremely large amounts of data in their research and development. To keep their overview and also use data from other departments they require campus-wide, inter-lingual search machines with semantic inter-operability for purposes of avoiding redundancies and providing a quicker, more efficient development of medicines.

Should these already be in use, pharmaceutical companies often receive insufficient information on their side effects, intolerance or efficacy. Here, automatic access to anonymized clinical data as well as its evaluation provides significantly higher patient safety. In addition, existing data can be used in retrospect to detect possible correlations.

Search without limits

According to the present legislation, pharmaceutical companies must provide a telephone hotline for all countries delivered to in their respective languages. Central, inter-lingual search technologies can save considerable time and significantly improve customer service here as well. The company-internal analysis of competitive information is also considerably more simple and quick.